X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
59
PharmaCompass offers a list of Emedastine Fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Emedastine Fumarate manufacturer or Emedastine Fumarate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Emedastine Fumarate manufacturer or Emedastine Fumarate supplier.
PharmaCompass also assists you with knowing the Emedastine Fumarate API Price utilized in the formulation of products. Emedastine Fumarate API Price is not always fixed or binding as the Emedastine Fumarate Price is obtained through a variety of data sources. The Emedastine Fumarate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Emedastine Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Emedastine Fumarate, including repackagers and relabelers. The FDA regulates Emedastine Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Emedastine Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Emedastine Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Emedastine Fumarate supplier is an individual or a company that provides Emedastine Fumarate active pharmaceutical ingredient (API) or Emedastine Fumarate finished formulations upon request. The Emedastine Fumarate suppliers may include Emedastine Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Emedastine Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Emedastine Fumarate DMF (Drug Master File) is a document detailing the whole manufacturing process of Emedastine Fumarate active pharmaceutical ingredient (API) in detail. Different forms of Emedastine Fumarate DMFs exist exist since differing nations have different regulations, such as Emedastine Fumarate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Emedastine Fumarate DMF submitted to regulatory agencies in the US is known as a USDMF. Emedastine Fumarate USDMF includes data on Emedastine Fumarate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Emedastine Fumarate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Emedastine Fumarate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Emedastine Fumarate Drug Master File in Japan (Emedastine Fumarate JDMF) empowers Emedastine Fumarate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Emedastine Fumarate JDMF during the approval evaluation for pharmaceutical products. At the time of Emedastine Fumarate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Emedastine Fumarate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Emedastine Fumarate Drug Master File in Korea (Emedastine Fumarate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Emedastine Fumarate. The MFDS reviews the Emedastine Fumarate KDMF as part of the drug registration process and uses the information provided in the Emedastine Fumarate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Emedastine Fumarate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Emedastine Fumarate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Emedastine Fumarate suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Emedastine Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Emedastine Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Emedastine Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Emedastine Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Emedastine Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Emedastine Fumarate suppliers with NDC on PharmaCompass.
Emedastine Fumarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Emedastine Fumarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Emedastine Fumarate GMP manufacturer or Emedastine Fumarate GMP API supplier for your needs.
A Emedastine Fumarate CoA (Certificate of Analysis) is a formal document that attests to Emedastine Fumarate's compliance with Emedastine Fumarate specifications and serves as a tool for batch-level quality control.
Emedastine Fumarate CoA mostly includes findings from lab analyses of a specific batch. For each Emedastine Fumarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Emedastine Fumarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Emedastine Fumarate EP), Emedastine Fumarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Emedastine Fumarate USP).
Market Place
